| 英文名称 |
中文名称 |
CAS号 |
操作 |
| ICAM-1-IN-1 |
251994-14-6 |
251994-14-6 |
详细
|
| KDM5A-IN-1 |
1905481-36-8 |
1905481-36-8 |
详细
|
| A-196 |
1982372-88-2 |
1982372-88-2 |
详细
|
| ME0328 |
ME0328 |
1445251-22-8 |
详细
|
| BI-7273 |
CS-2327 |
1883429-21-7 |
详细
|
| MS049 |
1502816-23-0 |
1502816-23-0 |
详细
|
| Dynamin inhibitory peptide |
P4 |
251634-21-6 |
详细
|
| HSDVHK-NH2 |
P11 |
848644-86-0 |
详细
|
| DynaMin inhibitory peptide, myristoylated |
MYR-GLN-PRO-PRO-ALA-SER-ASN-PRO-ARG-VAL-ARG-NH2 |
251634-22-7 |
详细
|
| Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA |
199807-33-5 |
199807-33-5 |
详细
|
| Vedolizumab |
维多珠单抗 |
943609-66-3 |
详细
|
| (Rac)-BAY1238097 |
(RAC)-BAY1238097 |
1564268-19-4 |
详细
|
| GSK1379725A |
1802251-00-8 |
1802251-00-8 |
详细
|
| Sirt2-IN-1 |
SIRT2-IN-1 |
1862238-00-3 |
详细
|
| HJB97 |
|
2093391-24-1 |
详细
|
| INCB054329 |
1628607-64-6 |
1628607-64-6 |
详细
|
| CF53 |
CF53 |
1808160-52-2 |
详细
|
| SIRT5 inhibitor 1 |
2166487-21-2 |
2166487-21-2 |
详细
|
| PKC-theta inhibitor |
MDK-8650 |
736048-65-0 |
详细
|
| SGC-iMLLT |
SGC-IMLLT |
2255338-25-9 |
详细
|
| Nudifloramide |
1-甲基-6-氧代吡啶-3-甲酰胺 |
701-44-0 |
详细
|
| BI-9321 trihydrochloride |
BI-9321 trihydrochloride |
2387510-87-2 |
详细
|
| MRK-740 |
化合物 MRK-740 |
2387510-80-5 |
详细
|
| UBCS039 |
UBCS039 |
358721-70-7 |
详细
|
| PIN1 inhibitor API-1 |
O6-[4-(TRIFLUOROACETAMIDOMETHYL)BENZYL]GUANINE |
680622-70-2 |
详细
|
| GSK467 |
化合物GSK467 |
1628332-52-4 |
详细
|
| TCS 21311 |
TCS21311; TCS-21311 |
1260181-14-3 |
详细
|
| GNE-049 |
化合物 T15397 |
1936421-41-8 |
详细
|
| DCP-LA |
DCP-LA |
28399-31-7 |
详细
|
| DCPLA-ME |
DCPLA-ME |
56687-67-3 |
详细
|
| EB-47 dihydrochloride |
EB47; EB-47 |
1190332-25-2 |
详细
|
| BYK204165 |
4-((1-甲基-1H-吡咯-2-基)亚甲基)异喹啉-1,3(2H,4H)-二酮 |
1104546-89-5 |
详细
|
| GNE-781 |
GNE-781 |
1936422-33-1 |
详细
|
| GeA-69 |
N-(2-(9H-咔唑-1-基)苯基)乙酰胺 |
2143475-98-1 |
详细
|
| JFD00244 |
JFD00244 |
96969-83-4 |
详细
|
| Valemetostat tosylate |
VALEMETOSTAT TOSYLATE |
1809336-93-3 |
详细
|
| UNC0224 |
UNC 0224 |
1197196-48-7 |
详细
|
| UNC0321 |
UNC0321 |
1238673-32-9 |
详细
|
| EZM 2302 |
GSK 3359088 |
1628830-21-6 |
详细
|
| E-7386 |
E-7386 |
1799824-08-0 |
详细
|
| EBI-2511 |
化合物EBI-2511 |
2098546-05-3 |
详细
|
| CBP/EP300-IN-1 |
Benzoic acid, 3-[[(1-acetyl-5-methoxy-1H-indol-3-yl)carbonyl]amino]-4-fluoro-, 1,1-dimethylethyl ester |
2443789-32-8 |
详细
|
| Y06036 |
Y06036 |
1832671-96-1 |
详细
|
| Y06137 |
Y06137 |
2226534-49-0 |
详细
|
| EHMT2-IN-2 |
EHMT2-IN-2 |
2230850-47-0 |
详细
|
| BRD7-IN-1 |
化合物BRD7-IN-1 |
2448414-48-8 |
详细
|
| MT1 |
MT1 BET INHIBITOR |
2060573-82-0 |
详细
|
| ZL0420 |
ZL0420 |
2230496-80-5 |
详细
|
| NCGC00247743 |
1435192-04-3 |
1435192-04-3 |
详细
|
| BAY1238097 |
BAY1238097 |
1564268-08-1 |
详细
|
| (R)-BAY1238097 |
(R)-BAY1238097 |
1564269-85-7 |
详细
|
| GNA002 |
GNA002 |
1385035-79-9 |
详细
|
| A-395 |
化合物A-395 |
2089148-72-9 |
详细
|
| JNJ-64619178 |
CS-2829 |
2086772-26-9 |
详细
|
| IACS-9571 hydrochloride |
IACS-9571 hydrochloride |
2319611-93-1 |
详细
|
| MOZ-IN-2 |
MOZ-IN-2 |
2055397-88-9 |
详细
|
| BET bromodomain inhibitor |
化合物BET BROMODOMAIN INHIBITOR |
1505453-59-7 |
详细
|
| CMPD101 |
CMPD101 |
865608-11-3 |
详细
|
| T-3775440 hydrochloride |
T-3775440盐酸盐 |
1422535-52-1 |
详细
|
| Fasudil Hydrochloride |
盐酸法舒地尔 |
105628-07-7 |
详细
|
| PROTAC Sirt2 Degrader-1 |
2MG |
2098487-75-1 |
详细
|
| PF-06726304 |
PF-06726304 |
1616287-82-1 |
详细
|
| Seclidemstat |
SECLIDEMSTAT |
1423715-37-0 |
详细
|
| GSK2807 Trifluoroacetate |
GSK2807 Trifluoroacetate |
2245255-66-5 |
详细
|
| QC6352 |
QC6352 |
1851373-36-8 |
详细
|
| CAY10602 |
1-(4-氟苯基)-3-(苯磺酰基)-1H-吡咯并[2,3-B]喹喔啉-2-胺 |
374922-43-7 |
详细
|
| SRT 1720 |
N-[2-[3-(1-哌嗪基甲基)咪唑并[2,1-B]噻唑-6-基]苯基]-2-喹喔啉甲酰胺 |
925434-55-5 |
详细
|
| Niraparib hydrochloride |
MK-4827 |
1038915-64-8 |
详细
|
| Niraparib (R-enantiomer) |
MK-4827 (R-enantioMer) |
1038915-58-0 |
详细
|
| Delcasertib |
Delcasertib |
949100-39-4 |
详细
|
| SB-218078 |
SB218078 |
135897-06-2 |
详细
|
| BAY-299 |
BAY-299 |
2080306-23-4 |
详细
|
| GSK8573 |
GSK8573 |
1693766-04-9 |
详细
|
| R 59-022 |
化合物 T16709 |
93076-89-2 |
详细
|
| Bisindolylmaleimide X hydrochloride |
BISINDOLYLMALEIMIDE X HYDROCHLORIDE (BIM-X HYDROCHLORIDE) |
145317-11-9 |
详细
|
| KDM5-IN-1 |
1628210-26-3 |
1628210-26-3 |
详细
|
| TP-472 |
TP-472 |
2079895-62-6 |
详细
|
| SGC2085 |
SGC2085 |
1821908-48-8 |
详细
|
| Cl-amidine hydrochloride |
N-[(1S)-1-(氨基羰基)-4 -[(2 - 氯-1-亚氨基乙基氨基]丁基]-苯甲酰胺盐酸盐 |
1373232-26-8 |
详细
|
| Hispidin |
6-[(1E)-2-(3,4-二羟基苯基)乙烯基]-4-羟基-2H-吡喃-2-酮 |
555-55-5 |
详细
|
| AZD5153 6-Hydroxy-2-naphthoic acid |
AZD5153结晶体(API形式) |
1869912-40-2 |
详细
|
| Lin28-let-7a antagonist 1 |
Lin28-IN-1 |
2024548-03-4 |
详细
|
| TPOP146 |
2018300-62-2 |
2018300-62-2 |
详细
|
| GNE-272 |
1936428-93-1 |
1936428-93-1 |
详细
|
| GSK9311 |
1923851-49-3 |
1923851-49-3 |
详细
|
| Histone Acetyltransferase Inhibitor II |
组蛋白乙酰转移酶 抑制剂II |
932749-62-7 |
详细
|
| HA-100 |
1-(5-异喹啉磺酰基)哌嗪盐酸盐 |
84468-24-6 |
详细
|
| GSK 4027 |
化合物 T11495L |
2079896-25-4 |
详细
|
| GSK4028 |
2079886-19-2 |
2079886-19-2 |
详细
|
| D-erythro-Sphingosine |
D-鞘氨醇 |
123-78-4 |
详细
|
| PBIT |
2 - (4 - Methylphenyl) - 1,2 - benzisothiazol - 3(2H)-one |
2514-30-9 |
详细
|
| AK-1 |
SIRT2 Inhibitor II, AK-1 |
330461-64-8 |
详细
|
| (S)-JQ-35 |
1349719-98-7 |
1349719-98-7 |
详细
|
| BJE6-106 |
BJE6-106 |
1564249-38-2 |
详细
|
| PARP14 inhibitor H10 |
PARP14 INHIBITOR H10 |
2084811-68-5 |
详细
|
| MS402 |
MS-402 |
1672684-68-2 |
详细
|
| CMP-5 |
1-(9-ethyl-9H-carbazol-3-yl)-N-(pyridin-2-ylmethyl)methanamine |
880813-42-3 |
详细
|
| MM-102 TFA |
1883545-52-5 |
1883545-52-5 |
详细
|
| KDM5-C70 |
ethyl 2-(((2-((2-(dimethylamino)ethyl)(ethyl)amino)-2-oxoethyl)amino)methyl)isonicotinate |
1596348-32-1 |
详细
|
| GNE-207 |
化合物 T15399 |
2158266-58-9 |
详细
|